Keytruda
Lung cancer drug made 'huge difference'
A woman whose husband died of lung cancer last year is delivering a petition to parliament calling on the government to fund more lung cancer medications. Audio
Lung cancer patients call for funded Keytruda
Patients with lung cancer say they urgently need better-funded treatments for the disease, including Keytruda.
Lung cancer sufferers hope they'll get access to Keytruda
About five New Zealanders die from lung cancer every day and now that Medsafe has just approved use of Keytruda for some lung cancers, patients have their fingers crossed that they'll be next in line… Audio
Lung cancer patients want access to Keytruda
Patients with deadly lung cancer say they must be next in line for access to the hotly debated and expensive drug Keytruda.
Pharmac urged to fund Keytruda for other cancers
A cancer patient given just two days to live five months ago is calling for Keytruda to be publicly funded for cancers other than melanoma. Audio
Pharmac urged to fund Keytruda for other cancers
A cancer patient given just two days to live five months ago is calling on Pharmac to publicly fund Keytruda for cancers other than melanoma. Audio
Melanoma patient Jeffrey Patterson dies
Melanoma patient Jeffrey Patterson spoke to Checkpoint earlier this year as he prepared to take a petition to Parliament calling for an immunotherapy drug to be funded. He died on Saturday night. Video, Audio
NZ lagging in melanoma drug funding - study
New Zealand is still far behind Australia and the United Kingdom when it comes to funding of melanoma drugs, according to a new study.
Pharmac criticised for waiting too long to fund Keytruda
A woman who had Stage IV melanoma has criticised Pharmac for not funding Keytruda earlier, saying hundreds of lives could have been saved. Video
Pharmac called on to improve funding practices
Melanoma sufferers who missed out on Keytruda, now funded by Pharmac, are still paying the price, a parliamentary select committee has been told. Audio
Delivering new melanoma drugs to cost DHBs over $1 million
While Pharmac's decision to fund the hotly-debated melanoma drug Keytruda is being welcomed, cash-strapped district health boards face costs of more than a million dollars to deliver the long-awaited… Audio
Life-saving melanoma drug rollout to cost DHBs 'millions'
District health boards face costs of more than $1 million to deliver long-awaited new melanoma drugs to patients.
Pharmac explains Keytruda deal timing
Pharmac's decision to fund a new - and expensive - drug for advanced melanoma was based on new trial research released in the last few months, it says. Video
Why did Pharmac wait on funding Opdivo, Keytruda?
Why did cancer patients in New Zealand have to wait so long for Keytruda? Sarah Fitt, Pharmac's Director of Operations, joins Checkpoint. Audio
Advanced melanoma patient receives Keytruda infusion
From today, patients with advanced melanoma will be able to access two publicly funded immunotherapy treatments - Opdivo and Keytruda, including Aucklander Barry Hawes. Video, Audio
Cancer Society welcomes Keytruda decision
The Cancer Society says it was nonsense for Pharmac to suggest the research behind Keytruda was a reason not to fund the drug. We talk to the society's medical director, Chris Jackson. Audio
Pharmac reaches "commercially favourable" Keytruda agreement
Melanoma sufferers and cancer groups say Pharmac plans to fund the advanced melanoma drug Keytruda will save lives and change lives. We talk to Pharmac's Sarah Fitt about why Pharmac changed its mind.
…Cancer groups say Keytruda funding a breakthrough
Melanoma patients and cancer groups say Pharmac's plans to fund the advanced melanoma drug Keytruda will save lives and change lives. Sharon Brettkelly reports. Audio
Pharmac agrees plan to fund Keytruda
A melanoma patient who cashed in her retirement savings to pay for Keytruda is welcoming Pharmac's plan to fund the expensive drug. Video
Mike Berridge: mitochondria, DNA and disease
Kim Hill talks to the Distinguished Research Fellow and Group Leader, Cancer Cell and Molecular Biology at the Malaghan Institute of Medical Research, who is co-leader of a world-first research… Audio
